PRAMIPEXOLE GxP pramipexole dihydrochloride 0.25 mg tablets blister pack
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
26-11-2017
अनुरोध भेजा।
सक्रिय संघटक:
pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg
थमां उपलब्ध:
Arrotex Pharmaceuticals Pty Ltd
INN (इंटरनेशनल नाम):
pramipexole dihydrochloride monohydrate
फार्मास्यूटिकल फॉर्म:
Tablet, uncoated
रचना:
Excipient Ingredients: mannitol; pregelatinised maize starch; magnesium stearate; povidone; silicon dioxide
प्रशासन का मार्ग:
Oral
पैकेज में यूनिट:
10, 30, 100
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.
उत्पाद समीक्षा:
Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
प्राधिकरण का दर्जा:
Licence status A
प्राधिकरण की तारीख:
2014-09-23
